Korean Gastric Cancer Association- Led Nationwide Survey on Surgically Treated Gastric Cancers in 2019 [PDF]
, 2021 Purpose: The Korean Gastric Cancer Association (KGCA) has been conducting nationwide surveys on patients with surgically treated gastric cancer, every 5 years, since 1995. This study details the results of the survey conducted in 2019.
권인규
core +1 more source
A Standardized Pathology Report for Gastric Cancer: 2nd Edition [PDF]
, 2023 The first edition of ‘A Standardized Pathology Report for Gastric Cancer’ was initiated by the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists and published 17 years ago. Since then, significant advances have been made in the
김현기, 최윤정
core +1 more source
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach [PDF]
, 2023 Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this is the 4th gastric cancer guideline published in Korea which is the revised version of previous evidence-based approach in 2018.
정민규 +3 more
core +1 more source
The Lancet, 2009 Gastric cancer is the second most frequent cause of cancer death worldwide, although much geographical variation in incidence exists. Prevention and personalised treatment are regarded as the best options to reduce gastric cancer mortality rates. Prevention strategies should be based on specific risk profiles, including Helicobacter pylori genotype ...
Hartgrink, HH +3 more
openaire +4 more sources
Chylous Ascites After Gastric Cancer Surgery: Risk Factors and Treatment Results [PDF]
, 2023 Purpose: Although chylous ascites is a frequent complication of radical gastrectomy for gastric cancer, proper diagnostic criteria and optimal treatment strategies have not been established.
박성현 +5 more
core +1 more source
Molecular diagnosis for personalized target therapy in gastric cancer [PDF]
, 2013 Gastric cancer is the second leading cause of cancer-related deaths worldwide. In advanced and metastatic gastric cancer, the conventional chemotherapy with limited efficacy shows an overall survival period of about 10 months.
조재용
core +1 more source
Endoscopic Resection of Undifferentiated-type Early Gastric Cancer [PDF]
, 2021 Early detection of gastric cancer is crucial because the survival rate can be improved through curative treatment. Although surgery and gastrectomy with lymph node dissection remain as the gold standard for curative treatment, early gastric cancer (EGC ...
이아영
core +1 more source
Prognostic value of tumoral expression of galectin-9 in gastric cancer
The Turkish Journal of Gastroenterology, 2017 Background/Aims: Galectin-9 (Gal-9) is a member of the β-galactoside-binding lectin family. Our previous study revealed that Gal-9 suppresses migration, invasion, and epithelial-mesenchymal transition in gastric cancer cells.
Sang Il Choi +5 more
doaj +1 more source
Clinical Implications of Microsatellite Instability in Early Gastric Cancer [PDF]
, 2019 Purpose: We aimed to evaluate the clinical characteristics of microsatellite instability in early gastric cancer. Materials and methods: The microsatellite instability status of resected early gastric tumors was evaluated using two mononucleotide ...
손태일 +11 more
core +1 more source
Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter Cohort Study [PDF]
, 2022 Purpose: Tegafur/gimeracil/oteracil (S-1) and capecitabine plus oxaliplatin (CAPOX) are standard adjuvant chemotherapies (ACs) administered after gastrectomy to patients with stage II or III gastric cancer. However, the efficacy of AC in elderly patients
김형일
core +1 more source